Nadolol (BluePoint Laboratories)
Welcome to the PulseAid listing for the Nadolol drug offered from BluePoint Laboratories. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | BluePoint Laboratories |
NON-PROPRIETARY NAME: | Nadolol |
SUBSTANCE NAME: | NADOLOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-02-05 |
END MARKETING DATE: | 0000-00-00 |
Nadolol HUMAN PRESCRIPTION DRUG Details:
Item Description | Nadolol from BluePoint Laboratories |
LABELER NAME: | BluePoint Laboratories |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 80(mg/1) |
START MARKETING DATE: | 2014-02-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68001-219_28f6a109-ba4a-4713-988a-3e453c7446c6 |
PRODUCT NDC: | 68001-219 |
APPLICATION NUMBER: | ANDA074501 |
Other NADOLOL Pharmaceutical Manufacturers / Labelers: